These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22408372)
1. Chorea as a first manifestation in young patients with systemic lupus erythematosus who was initially diagnosed with rheumatic Fever. Albishri JA Clin Med Insights Case Rep; 2012; 5():19-21. PubMed ID: 22408372 [TBL] [Abstract][Full Text] [Related]
2. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Breda L; Nozzi M; De Sanctis S; Chiarelli F Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077 [TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535 [TBL] [Abstract][Full Text] [Related]
6. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman. Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069 [TBL] [Abstract][Full Text] [Related]
7. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study. Chen J; Sun S; Yan Q; Bao C; Fu Q Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909 [TBL] [Abstract][Full Text] [Related]
9. Chorea as a Manifestation of Systemic Lupus Erythematosus. Medeiros T; Vilas-Boas A; Carvalho V; Santos T; Pinho A Cureus; 2023 Mar; 15(3):e35884. PubMed ID: 37033559 [TBL] [Abstract][Full Text] [Related]
10. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL). Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY Front Immunol; 2019; 10():885. PubMed ID: 31134052 [TBL] [Abstract][Full Text] [Related]
12. Chorea and retinal vessel occlusion in a patient with systemic lupus erythematosus. Ostovan VR; Ghorbani A Iran J Neurol; 2013; 12(2):66-8. PubMed ID: 24250905 [TBL] [Abstract][Full Text] [Related]
13. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Amital H; Langevitz P; Levy Y; Afek A; Goldberg I; Pras M; Livneh A; Shoenfeld Y Clin Exp Rheumatol; 1999; 17(1):99-102. PubMed ID: 10084041 [TBL] [Abstract][Full Text] [Related]
15. Recurrent antiphospholipid-related deep vein thrombosis as presenting manifestation of systemic lupus erythematosus. Gattorno M; Molinari AC; Buoncompagni A; Acquila M; Amato S; Picco P Eur J Pediatr; 2000 Mar; 159(3):211-4. PubMed ID: 10664237 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Love PE; Santoro SA Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus. Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699 [TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]